Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karolina Pavic

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Chembiochem : a European Journal of Chemical Biology|May 5, 2012
Chemical biology techniques unlock the secrets of casein kinase 2 regulation by phosphorylation and glycosylationKarolina Pavic, Maja Köhn
The FEBS Journal|March 12, 2015
VHR/DUSP3 phosphatase: structure, function and regulationKarolina Pavic, Guangyou Duan, Maja Köhn
Advances in Cancer Research|February 1, 2022
Drug targeting opportunities en route to Ras nanoclustersKarolina Pavic, Rohan Chippalkatti, Daniel Abankwa
STAR Protocols|September 29, 2024
Protocol to measure and analyze protein interactions in mammalian cells using bioluminescence resonance energy transferCarla Jane Duval, Candy Laura Steffen, Karolina Pavic, et al.
Chembiochem : a European Journal of Chemical Biology|October 20, 2018
Interrogating PP1 Activity in the MAPK Pathway with Optimized PP1-Disrupting PeptidesYansong Wang, Bernhard Hoermann, Karolina Pavic, et al.
ACS Chemical Biology|May 7, 2014
Unnatural amino acid mutagenesis reveals dimerization as a negative regulatory mechanism of VHR's phosphatase activityKarolina Pavic, Pablo Rios, Kristina Dzeyk, et al.
Biochemistry|August 3, 2011
The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositidesVictoria McParland, Giulia Varsano, Xun Li, et al.
Cancers|March 6, 2021
Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-SignalingFarid Ahmad Siddiqui, Hanna Parkkola, Vladimir Vukic, et al.
EMBO Reports|February 9, 2017
Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56Jiao Wang, Juha Okkeri, Karolina Pavic, et al.
Journal of Medicinal Chemistry|May 17, 2024
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit <i>KRAS</i> Mutant Cancer Cell GrowthPelin Kaya, Elisabeth Schaffner-Reckinger, Ganesh Babu Manoharan, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Chembiochem : a European Journal of Chemical Biology|May 5, 2012
Chemical biology techniques unlock the secrets of casein kinase 2 regulation by phosphorylation and glycosylationKarolina Pavic, Maja Köhn
The FEBS Journal|March 12, 2015
VHR/DUSP3 phosphatase: structure, function and regulationKarolina Pavic, Guangyou Duan, Maja Köhn
Advances in Cancer Research|February 1, 2022
Drug targeting opportunities en route to Ras nanoclustersKarolina Pavic, Rohan Chippalkatti, Daniel Abankwa
STAR Protocols|September 29, 2024
Protocol to measure and analyze protein interactions in mammalian cells using bioluminescence resonance energy transferCarla Jane Duval, Candy Laura Steffen, Karolina Pavic, et al.
Chembiochem : a European Journal of Chemical Biology|October 20, 2018
Interrogating PP1 Activity in the MAPK Pathway with Optimized PP1-Disrupting PeptidesYansong Wang, Bernhard Hoermann, Karolina Pavic, et al.
ACS Chemical Biology|May 7, 2014
Unnatural amino acid mutagenesis reveals dimerization as a negative regulatory mechanism of VHR's phosphatase activityKarolina Pavic, Pablo Rios, Kristina Dzeyk, et al.
Biochemistry|August 3, 2011
The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositidesVictoria McParland, Giulia Varsano, Xun Li, et al.
Cancers|March 6, 2021
Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-SignalingFarid Ahmad Siddiqui, Hanna Parkkola, Vladimir Vukic, et al.
EMBO Reports|February 9, 2017
Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56Jiao Wang, Juha Okkeri, Karolina Pavic, et al.
Journal of Medicinal Chemistry|May 17, 2024
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit <i>KRAS</i> Mutant Cancer Cell GrowthPelin Kaya, Elisabeth Schaffner-Reckinger, Ganesh Babu Manoharan, et al.
Pageof 2